Over the past 12‑18 months, the Safety Testing of Daily Chemical Care Products industry trends have accelerated through strategic alliances, regulatory shifts, and technology roll‑outs. In Q2 2023, Procter & Gamble partnered with Biosafe Labs to embed AI‑driven toxicity prediction into its in‑house testing pipeline, cutting assay time by 30%. The same year, Eurofins Scientific acquired ToxCheck, a European startup specializing in microfluidic skin‑irritation platforms, expanding its service footprint across the EU. In early 2024, Colgate‑Palmolive launched a blockchain‑based traceability system for ingredient safety data, setting a new benchmark for transparency. Regulatory momentum surged as the EU’s updated REACH amendment (effective Jan 2024) introduced mandatory in‑silico assessments for surfactants, prompting many manufacturers to upgrade their digital validation tools. Consumer demand for “clean‑label” formulations drove a 22 % rise in third‑party certification requests, while venture capital poured $85 million into startups focusing on rapid, non‑animal testing methods, fueling further innovation and capacity expansion. These dynamics position the sector for sustained growth through 2026.